Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT01566721 |
| Title | A Safety and Tolerability Study of Assisted- and Self-Administered Subcutaneous Herceptin (Trastuzumab) as Adjuvant Therapy in Patients With Early HER2-Positive Breast Cancer (SafeHer) |
| Acronym | SafeHER |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | No |
| Sponsors | Hoffmann-La Roche |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | TUR | SWE | SVN | SVK | ROU | POL | NZL | NOR | NLD | LTU | ITA | IRL | HUN | HRV | GRC | GBR | FRA | ESP | DEU | CZE | CHE | CAN | BRA | BGR | AUS | ARG |